InvestorsHub Logo
Followers 63
Posts 7611
Boards Moderated 1
Alias Born 01/02/2003

Re: alm2 post# 296415

Friday, 09/04/2020 4:51:01 PM

Friday, September 04, 2020 4:51:01 PM

Post# of 430347
Alms...I agree...Why not cut expenses and deal from strength while awaiting a legitimate BO offer?...The additional revenues will not make up for the expenses of supporting a team of 800 reps, especially with the Generics standing by in the wings....A profitable Amarin will attract better buying interests..Later on, Amarin or whatever company owns it can sell Vascepa OTC.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News